AbCellera Biologics (ABCL) PT Lowered to $38 at Berenberg

February 22, 2023 6:24 AM EST
Get Alerts ABCL Hot Sheet
Price: $11.38 +3.74%

Rating Summary:
    12 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Berenberg analyst Gaurav Goparaju lowered the price target on AbCellera Biologics (NASDAQ: ABCL) to $38.00 (from $43.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change